Effects of (-)-nicotine and (-)-cotinine on 6-hydroxydopamine-induced oxidative stress and neurotoxicity: relevance for Parkinson's disease (Q44054393)

29 November 2017

title

Effects of (-)-nicotine and (-)-cotinine on 6-hydroxydopamine-induced oxidative stress and neurotoxicity: relevance for Parkinson's disease (English)

1 reference

29 November 2017

1 reference

1 reference

1 reference

Ramón Soto-Otero

1 reference

29 November 2017

Estefanía Méndez-Alvarez

1 reference

29 November 2017

Alvaro Hermida-Ameijeiras

1 reference

29 November 2017

Ana María López-Real

1 reference

29 November 2017

José Luis Labandeira-García

1 reference

29 November 2017

language of work or name

English

0 references

publication date

1 July 2002

1 reference

29 November 2017

published in

Biochemical Pharmacology

1 reference

29 November 2017

1 reference

29 November 2017

1 reference

29 November 2017

page(s)

125-135

1 reference

The brain-stem lesions in Parkinsonism

29 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2901070-5

Parkinson's disease: pathophysiology

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2901070-5

Free radicals and mitochondrial dysfunction in Parkinson's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2901070-5

Brain iron pathways and their relevance to Parkinson's disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2901070-5

The Pivotal Role of Iron in NF-kappaB Activation and Nigrostriatal Dopaminergic Neurodegeneration: Prospects for Neuroprotection in Parkinson's Disease with Iron Chelators

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2901070-5

A retrospective study of smoking in Parkinson's disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2901070-5

Cigarette smoking and Parkinson's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2901070-5

Cigarette smoking and protection from Parkinson's disease: false association or etiologic clue?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2901070-5

Smoking and Parkinson's disease: a case-control study in Germany

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2901070-5

Cigarette smoking and the incidence of Parkinson's disease in two prospective studies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2901070-5

Effects of nicotine on hydroxyl free radical formation in vitro and on MPTP-induced neurotoxicity in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2901070-5

In vitro and in vivo studies investigating possible antioxidant actions of nicotine: relevance to Parkinson's and Alzheimer's diseases.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2901070-5

Free radical production in nicotine treated pancreatic tissue

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2901070-5

Comparison of pure nicotine- and smokeless tobacco extract-induced toxicities and oxidative stress

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2901070-5

Nicotine enhances 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine neurotoxicity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2901070-5

Chronic continuous infusion of (-)nicotine reduces basic fibroblast growth factor messenger RNA levels in the ventral midbrain of the intact but not of the 6-hydroxydopamine-lesioned rat

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2901070-5

Nicotine prevents striatal dopamine loss produced by 6-hydroxydopamine lesion in the substantia nigra

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2901070-5

Interaction of 1,2,3,4-Tetrahydroisoquinoline with Some Components of Cigarette Smoke: Potential Implications for Parkinson's Disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2901070-5

Inhibition of brain monoamine oxidase by adducts of 1,2,3,4-tetrahydroisoquinoline with components of cigarette smoke

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2901070-5

Studies on the interaction between 1,2,3,4-tetrahydro-beta-carboline and cigarette smoke: a potential mechanism of neuroprotection for Parkinson's disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2901070-5

Reduction of rat brain levels of the endogenous dopaminergic proneurotoxins 1,2,3,4-tetrahydroisoquinoline and 1,2,3,4-tetrahydro-beta-carboline by cigarette smoke.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2901070-5

Mass fragmentography of dopamine and 6-hydroxydopamine. Application to the determination of dopamine in human brain biopsies from the caudate nucleus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2901070-5

The determination of hydroxydopamines and other trace amines in the urine of parkinsonian patients and normal controls

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2901070-5

Intermediates in the aerobic autoxidation of 6-hydroxydopamine: relative importance under different reaction conditions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2901070-5

Vitamin E attenuates the toxic effects of intrastriatal injection of 6-hydroxydopamine (6-OHDA) in rats: behavioral and biochemical evidence

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2901070-5

The iron chelator desferrioxamine (Desferal) retards 6-hydroxydopamine-induced degeneration of nigrostriatal dopamine neurons

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2901070-5

Free radical-generated neurotoxicity of 6-hydroxydopamine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2901070-5

Autoxidation and Neurotoxicity of 6-Hydroxydopamine in the Presence of Some Antioxidants

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2901070-5

Nature of inhibition of mitochondrial respiratory complex I by 6-Hydroxydopamine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2901070-5

Time course of striatal changes induced by 6-hydroxydopamine lesion of the nigrostriatal pathway, as studied by combined evaluation of rotational behaviour and striatal Fos expression.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2901070-5

Progressive degeneration of nigrostriatal dopamine neurons following intrastriatal terminal lesions with 6-hydroxydopamine: a combined retrograde tracing and immunocytochemical study in the rat.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2901070-5

Dose-dependent lesions of the dopaminergic nigrostriatal pathway induced by intrastriatal injection of 6-hydroxydopamine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2901070-5

Dopamine cell degeneration induced by intraventricular administration of 6-hydroxydopamine in the rat: similarities with cell loss in parkinson's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2901070-5

The effects of derangement of cell membrane structure and inhibitors on transferrin and iron uptake by reticulocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2901070-5

Effect of nicotine on transferrin binding and iron uptake by cultured rat placenta

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2901070-5

Effects of superoxide dismutase and catalase on catalysis of 6-hydroxydopamine and 6-aminodopamine autoxidation by iron and ascorbate

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2901070-5

A modification of the Lowry procedure to simplify protein determination in membrane and lipoprotein samples

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2901070-5

In vitro inhibition of catalase activity by cigarette smoke: relevance for oxidative stress

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2901070-5

Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2901070-5

Mechanism of inhibitory effects of chelating drugs on lipid peroxidation in rat brain homogenates

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2901070-5

Polyphenol tannic acid inhibits hydroxyl radical formation from Fenton reaction by complexing ferrous ions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2901070-5

Interactions between metals, ligands, and oxygen in the autoxidation of 6-hydroxydopamine: mechanisms by which metal chelation enhances inhibition by superoxide dismutase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2901070-5

Oxygen toxicity, oxygen radicals, transition metals and disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2901070-5

Reactive oxygen species and the central nervous system

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2901070-5

Transition Metals, Ferritin, Glutathione, and Ascorbic Acid in Parkinsonian Brains

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2901070-5

Iron and aluminum increase in the substantia nigra of patients with Parkinson's disease: an X-ray microanalysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2901070-5

Iron accumulation in the substantia nigra in rats visualized by ultrasound

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2901070-5

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2901070-5

Acute intermittent nicotine treatment produces regional increases of basic fibroblast growth factor messenger RNA and protein in the tel- and diencephalon of the rat.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2901070-5

Nicotine prevents experimental parkinsonism in rodents and induces striatal increase of neurotrophic factors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2901070-5

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0006-2952(02)01070-5

1 reference

29 November 2017

1 reference